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VARIATION IN THE BACTERICIDAL/PERMEABILITY INCREASING PRO-
TEIN GENE INFLUENCES THE RISK OF DEVELOPING RAPID AIRFLOW
DECLINE AFTER HEMATOPOIETIC CELL TRANSPLANTATION
Chien, J.W., Zhao, L.P., Hansen, J.A., Fan, W.H., Parimon, T.,
Clark, J.G. Fred Hutchinson Cancer Research Center, Seattle, WA.
Signiﬁcant airﬂow decline affects up to 26% of patients who
receive a hematopoietic cell transplant. Since innate immunity is
involved in the biology of graft versus host disease and common
airways diseases, we screened 15 genes in this pathway using a
haplotype approach to identify genes that are critical to the devel-
opment of this syndrome. The presence or absence of signiﬁcant
airﬂow decline, deﬁned as a 	5% annualized rate of one second
forced expiratory volume decrease after transplant, was determined
in discovery (n 363) and validation (n 209) cohorts. Sixty-nine
haplotype tagging single nucleotide polymorphisms were selected
for the initial screen. Expression of the candidate gene was dem-
onstrated by detecting gene transcript and protein in malignant
and normal small airway epithelial cells. In the discovery cohort,
133 patients developed signiﬁcant airﬂow decline. Four patient and
donor bactericidal permeability increasing (BPI) haplotypes were
signiﬁcantly associated with a 2 to 3-fold increased risk for devel-
oping signiﬁcant airﬂow decline (P  .004 to .038). This associa-
tion was conﬁrmed in the validation cohort, which had 66 patients
with signiﬁcant airﬂow decline, with 9 signiﬁcant haplotypes (P 
.013 to .043). Patient haplotypes on the lipopolysaccharide binding
protein (LBP) gene, located directly adjacent to the BPI gene on
chromosome 20, were also associated with the phenotype. Fine-
mapping studies of the 1-mb region surrounding the BPI gene
indicated there was no evidence of extended haplotype blocks and
the genomic region of highest association was conﬁrmed to be
within the BPI gene. BPI gene transcript and protein was detected
for the ﬁrst time in airway epithelial cells. These results indicate
that genetic variation affecting the BPI gene signiﬁcantly inﬂu-
ences the risk for developing rapid airﬂow decline after hemato-
poietic cell transplantation and may represent a novel therapeutic
target for this form of airways disease.
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IN VIVO TRAFFICKING AND PROLIFERATION OF NATURAL KILLER
CELLS IN MURINE MODELS OF BONE MARROW TRANSPLANTATION
Olson, J.A., Negrin, R.S. Stanford University, Stanford, CA.
The high incidence of graft versus host disease (GVHD) as a
complication of allogeneic hematopoietic cell transplantation has
limited its overall effectiveness in treating hematologic malignan-
cies. It has been shown that natural killer (NK) cells have the
capability of suppressing the development of GVHD while induc-
ing an anti-tumor response. Little is known about the trafﬁcking
patterns of NK cells following hematopoietic cell transplantation,
their proliferation or how long they persist in vivo. We investi-
gated the trafﬁcking patterns of NK cells in vivo in allogeneic and
syngeneic bone marrow transplant settings using a novel in vivo
bioluminescence imaging (BLI) technique. Freshly isolated NK
cells from FVB L2G85 gfp/luc transgenic mice, which can be
imaged by BLI, were transplanted along with T-cell depleted bone
marrow on day 0 into lethally irradiated BALB/c mice. In vivo and
ex vivo BLI of the transplanted mice on successive days post-
transplant indicated that in the allogeneic setting, NK cells trafﬁc
to distinct lymphoid organs, namely the peripheral and mesenteric
lymph nodes and spleen. The in vivo bioluminescent signal was
2.75-fold greater on day 6 than on day 2, indicating a signiﬁcant in
vivo expansion of the NK cells. In the syngeneic setting, NK cell
trafﬁcking to distinct lymphoid organs was not detected and min-
imal NK cell proliferation was visible by ex vivo BLI. To determine
the extent of NK cell proliferation in vivo, freshly isolated NK cells
were labeled with CFSE and transplanted into allogeneic and
syngeneic recipients. On day 5, FACS analysis of splenocytes
showed that 90% of donor CFSE labeled NK cells had divided in
the recipient spleen, undergoing at least 6 divisions. In the synge-
neic recipient, 59% of the CFSE labeled NK cells had divided,
with only 4 cell divisions visible. This corresponds to the BLI
signal and timing patterns seen in the spleens of both recipient
animals in ex vivo BLI images. These studies have characterized
the in vivo trafﬁcking and proliferation of NK cells in murine bone
marrow transplantation models. Continuing studies will aim to
identify what is responsible for the initiation and continuation of
allogeneic proliferation, and whether the in vivo expansion is
driven by NK cell receptor-ligand interactions or MHC class I
differences. Understanding NK cell trafﬁcking and proliferation
could provide novel insights into enhancing function of both in-
nate and adoptively transferred NK cells.
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DONOR CD8 T CELLS FACILITATE ENGRAFTMENT AND MEDIATE GVL
WITHOUT GVHD IN RECIPIENTS CONDITIONED WITH ANTI-CD3 MAB
Zhang, C.1, Lou, J.1, Huang, T.1, Todorov, I.1, Cao, Y.2, Contag, C.2,
Kandeel, F.1, Forman, S.1, Zeng, D.1 1. The Beckman Research Institute
of City of Hope, Duarte, CA; 2. Stanford University School of Medicine,
Stanford, CA.
Donor CD8 T cells play a critical role in facilitating engraft-
ment and mediating graft versus leukemia (GVL), but also induce
severe graft versus host disease (GVHD) in recipients conditioned
with total body irradiation (TBI) in murine as well as human
allogeneic hematopoietic cell transplantation (HCT). In the cur-
rent study, in a murine MHC-mismatched model of C57BL/6 or
FVB/N donor to BALB/c recipient, three injections of 5-20  106
donor CD8 T cells in combination with one injection of 50-
100  106 donor bone marrow (BM) cells induced complete
chimerism without signs of GVHD or lymphocyte inﬁltration in
skin or gut tissues in BALB/c recipients conditioned with anti-
CD3 mAb 7 days before donor cell injections. In contrast, the same
doses of donor CD8 T and BM cells induced lethal GVHD with
severe tissue inﬁltration in recipients conditioned with sublethal
TBI. Although donor CD8 T cells migrated to thymus in both
TBI-conditioned and anti-CD3-conditioned recipients, donor
CD8 T cells did not cause thymus tissue destruction in anti-
CD3-conditioned recipients, and the yield of total and
CD4CD8 thymocytes in anti-CD3-conditioned recipients was
100 fold higher than in TBI-conditioned recipients 30 days after
transplantation. In addition, donor CD8 T cells eliminate BCL1
tumor cells without causing GVHD in anti-CD3-conditioned re-
cipients. Using in vivo and in vitro bioluminescent imaging, we
found that donor CD8 T cells from luciferase transgenic mice
expanded rapidly and inﬁltrated GVHD target tissues (i.e. gut,
liver and lung) in TBI-conditioned recipients, but donor CD8 T
cell expansion in anti-CD3-conditioned recipients was conﬁned in
lympho-hematological tissues, especially in mesenteric lymph
nodes and Peyer’s patches. This conﬁnement was associated with
reduced production of pro-inﬂammatory cytokines (i.e. TNF-
)
and increased production of anti-inﬂammatory cytokines (i.e. IL-4
and IL-10) in anti-CD3-conditioned recipients compared to TBI-
conditioned recipients early after transplantation. Host residual
NKT cells appeared to be the source of IL-4 and IL-10 production
in anti-CD3-conditioned recipients. These results demonstrate
that anti-CD3-conditioning separates GVL from GVHD via con-
ﬁning donor CD8 T cell expansion to host lympho-hematolog-
ical tissues. This radiation-free and GVHD preventive regimen
may be useful for allogeneic HCT in treating malignancies and
autoimmune diseases, as well as transplantation tolerance induc-
tion.
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IN VIVO KINETICS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN CON-
DITIONED VS. UNCONDITIONED HOSTS
Beilhack, A.1, Wai, L.-E.1, Schulz, S.3, Beilhack, G.F.1, Nishimura, R.1,
Baker, E.M.1, Herman, E.I.1, Landan, G.1, Olson, J.A.1, Baker, J.1,
Contag, C.H.2, Negrin, R.S.1 1. Division of Blood & Marrow Trans-
plantation, Stanford University; 2. Department of Pediatrics, Stanford
University; 3. Institute of Pathology, Technical University Munich,
Germany.
Acute graft-versus-host disease (aGVHD) is a major limitation
for the broader applicability of allogeneic hematopoietic cell trans-
plantation (aHCT). Here we asked how the conditioning regimen
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